EconomyUS judge allows Eli Lilly to keep advertising weight-loss drugs, rules against Novo Nordisk
A US court on Monday allowed Eli Lilly to continue advertising its weight-loss drugs, rejecting rival Novo Nordisk’s claim that the ads were false and misleading.
R
Reuters★★☆☆☆2026-10-26 20:10Original
US judge allows Eli Lilly to keep advertising weight-loss drugs, rules against Novo Nordisk
Economy